Trials / Completed
CompletedNCT00368706
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients
A Randomized, Double-Blind, Paralleled, Active Controlled, Multi-Center Study of the Efficacy and Safety of 5mg Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 246 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of solifenacin succinate (Vesicare) 5mg OD in subjects with overactive bladder compared to tolterodine wmg, bid
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | solifenacin succinate | Oral |
| DRUG | tolterodine | oral |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2006-08-25
- Last updated
- 2008-04-10
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00368706. Inclusion in this directory is not an endorsement.